Streetbeat News

Products Services

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trade strategies for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. The memo outlines potential price targets and support levels for each asset, advising traders to monitor these stocks for breakouts or reversals and to stay alert for market volatility, especially with the upcoming FHFA House Price Index and JOLTS Job Openings data releases, as well as the FOMC rate decision.

Portfolio Pulse from RIPS

January 30, 2024 | 4:02 pm

TSNDF

This Valentine's Day, cannabis products are being highlighted as gifts for love and wellness. Dr. Norm's offers Solventless Hash Gummies in flavors like Key Lime High and Wicked Watermelon. Punch Edibles & Extracts introduces half-gram live rosin vape cartridges. Honest presents the Essentials Bundle with stylish smokeware. TerrAscend (OTC:TSNDF) features Valhalla Extra Strength Troches in various flavors and strengths. These products aim to provide a blend of romance, wellness, and indulgence for the occasion.

Portfolio Pulse from Nicolás Jose Rodriguez

January 30, 2024 | 3:58 pm

COIN

Coinbase Inc. (NASDAQ:COIN), a key custodian for Bitcoin ETFs, emphasizes its strong security measures and the benefits of ETFs for investors. The firm's chief security officer, Philip Martin, discussed the reduced custodial risks of ETFs compared to direct cryptocurrency ownership and the thorough vetting process Coinbase undergoes with ETF issuers. Martin also highlighted the potential for ETFs to attract new investors and the importance of robust security practices.

Portfolio Pulse from Murtuza Merchant

January 30, 2024 | 3:48 pm

ITRM

Iterum Therapeutics PLC (NASDAQ:ITRM) shares are trending after announcing positive topline results from its Phase 3 Reassure trial, meeting the primary endpoint of non-inferiority to Augmentin. The company plans to resubmit its NDA for oral sulopenem in Q2 2024 and is exploring strategic options to maximize stakeholder value. The stock is experiencing heavy trading volume, significantly above its 100-day average.

Portfolio Pulse from Erica Kollmann

January 30, 2024 | 3:47 pm

AMZN

IRBT

Amazon (NASDAQ:AMZN) has partnered with Mexican fintech firm Kueski to offer bi-weekly installment payments in Mexico, allowing customers to make purchases without a credit card. Kueski will manage financing and credit assessment. Amazon also terminated its merger with iRobot (NASDAQ:IRBT), resulting in a $94 million termination fee paid by Amazon. AMZN shares dropped slightly by 0.20% to $160.93.

Portfolio Pulse from Nabaparna Bhattacharya

January 30, 2024 | 3:36 pm

INTC

QCOM

TXN

Qualcomm Inc (NASDAQ:QCOM) is set to report Q1 earnings on Jan. 31 with expectations of $2.37 EPS and $9.51 billion in revenues. Analysts are focusing on Qualcomm's growth in the automotive sector, AI capabilities, and stock valuation. The company's Snapdragon 8 Gen 3 chips and Oryon series for laptops show its competitive edge. Qualcomm's automotive business grew 23% sequentially in fiscal Q4, and its AI technology is expected to drive demand for semiconductor chips. Despite a forward P/E of 14.21, lower than peers Intel (NASDAQ:INTC) and Texas Instruments (NASDAQ:TXN), Qualcomm is seen as undervalued. Analysts maintain a Buy rating with a price target of $135.97, with recent targets up to $175. Qualcomm's stock closed at $150.44 on Jan. 29.

Portfolio Pulse from Surbhi Jain

January 30, 2024 | 3:20 pm

AAOI

Applied Optoelectronics Inc (NASDAQ:AAOI) is expected to see significant growth in AI optical technology sales by 2025, according to Rosenblatt Securities analyst Mike Genovese. Genovese initiated coverage with a Buy rating and a $23 price target, citing the potential for AAOI to capture over 10% of the AI 800+G Optical transceiver market, which is projected to reach $7.5 billion. He also forecasts a revenue of $485 million for AAOI in 2025, which may be conservative given the expected 40% growth rate. The company's gross margins have already expanded by more than 1,000 basis points to around 30% in 2023 and are expected to continue growing. Genovese's EPS forecast for 2025 is $1.15, which is 23% above consensus. AAOI shares were up 8.2% to $17.36 following the coverage initiation.

Portfolio Pulse from Priya Nigam

January 30, 2024 | 3:13 pm

PBLA

Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares dropped over 2% on Tuesday after a 65.3% decline on Monday. The company announced an abstract for SBP-101 was accepted for a poster presentation at the American Association for Cancer Research. Panbela is collaborating with Johns Hopkins University School of Medicine on this. Additionally, Panbela disclosed the pricing of a public offering of 4.38 million shares or pre-funded warrants, with two classes of warrants to purchase up to 8.75 million shares. The common warrants have an exercise price of $2.06 per share and are exercisable immediately, expiring in five years. The offering aims to raise approximately $9.0 million and is expected to close by January 31, 2024. Last week, Panbela was in news for enrolling in the ASPIRE global clinical trial for metastatic pancreatic cancer treatment.

Portfolio Pulse from Nabaparna Bhattacharya

January 30, 2024 | 2:56 pm

MSFT

NVEI

Nuvei has announced the launch of its B2B technology integration with Microsoft Dynamics 365 Business Central, aimed at enhancing accounting workflows and payments for customers using the ERP system.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:32 pm

GILD